Skip to Main Content

Author Details

John M S Bartlett
University of Edinburgh
1992
307
70
PMIDPaper TitleJournal TitlePublished Year
36859649Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study.Breast Cancer Res Treat2023
37608772Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerJ Pathol2023
37608771Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.J Pathol2023
37126232Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.J Urol2023
37037938A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients.Br J Cancer2023
34902335Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.Lancet Oncol2022
35694787Correction: GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer.Clin Cancer Res2022
35526835Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer.J Mol Diagn2022
36527133Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study.Breast Cancer Res2022
36137393Selecting patients with HER2-low breast cancer: Getting out of the tangle.Eur J Cancer2022
35954426External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices.Cancers (Basel)2022
35043236Incorporation of TILs in daily breast cancer care: how much evidence can we bear?Virchows Arch2022
35144966Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study.Clin Cancer Res2022
34875674Multi-omic machine learning predictor of breast cancer therapy response.Nature2022
35027623Upregulation of IFNÉ£-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma.Sci Rep2022
33369635Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group.J Natl Cancer Inst2021
34638394Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group.Cancers (Basel)2021
34711609Heterogeneity of Circulating Tumor Cell-Associated Genomic Gains in Breast Cancer and Its Association with the Host Immune Response.Cancer Res2021
34238931Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study.NPJ Breast Cancer2021
34264305Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial.JAMA Oncol2021
34312396Evaluation of multiple transcriptomic gene risk signatures in male breast cancer.NPJ Breast Cancer2021
32156747GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer.Clin Cancer Res2020
32089356Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast Cancer.Clin Oncol (R Coll Radiol)2020
31964786A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer.Clin Cancer Res2020
31932696Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.Nat Genet2020
32051610Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.Nat Genet2020
33098760How current assay approval policies are leading to unintended imprecision medicine.Lancet Oncol2020
32881987Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training.PLoS One2020
32763409Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification-Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples.J Mol Diagn2020
32706636Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials.J Clin Oncol2020
33022560Can immune markers help identify fast relapse in patients with muscle invasive bladder cancer?Pathol Res Pract2020
32816949A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination-deficient Pancreatic Cancer.Clin Cancer Res2020
32129476The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.J Pathol2020
30686769Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.Cancer Cell2019
35100692Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy-Resistant Early Breast Cancers.JCO Precis Oncol2019
30143750An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.Mod Pathol2019
31322299Benchmarking to the Gold Standard: Hyaluronan-Oxime Hydrogels Recapitulate Xenograft Models with In Vitro Breast Cancer Spheroid Culture.Adv Mater2019
31433512A three-gene DNA methylation biomarker accurately classifies early stage prostate cancer.Prostate2019
31202397Combining clustering and classification ensembles: A novel pipeline to identify breast cancer profiles.Artif Intell Med2019
31017314Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.Histopathology2019
31070984Meta-Analysis of 1,200 Transcriptomic Profiles Identifies a Prognostic Model for Pancreatic Ductal Adenocarcinoma.JCO Clin Cancer Inform2019
31013327Correction: PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer.PLoS One2019
30629588Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer.PLoS Comput Biol2019
30604486Molecular profiling in muscle-invasive bladder cancer: more than the sum of its parts.J Pathol2019
29288237Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial.Clin Cancer Res2018
30029633Tumoral BRD4 expression in lymph node-negative breast cancer: association with T-bet+ tumor-infiltrating lymphocytes and disease-free survival.BMC Cancer2018
29917140Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial.J Natl Cancer Inst2018
30231409Incorporating Biology Into Breast Cancer Staging: American Joint Committee on Cancer, Eighth Edition, Revisions and Beyond.Am Soc Clin Oncol Educ Book2018
30066480Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients.J Pathol Clin Res2018
29846122Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.J Clin Oncol2018
  • 1 - 50 of 307

Recommended Authors

Martin Sj??str??m
University of California-San Francisco
Career Start Year 2013
Number of shared co-authors 3
Carmen Criscitiello
University of Milano
Career Start Year 2008
Number of shared co-authors 12
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 19
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 26
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Career Start Year 2003
Number of shared co-authors 15
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 20
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 6
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 25
Peter A Fasching
Otto-Friedrich-University Bamberg
Career Start Year 2002
Number of shared co-authors 41
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 11
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 35
Ole Christian Lingj??rde
University of Oslo
Career Start Year 1997
Number of shared co-authors 12
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 8
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 9
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 13
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 21
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 43
Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 12
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 7
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 17
Eberhard Korsching
Institutet of Bioinformatics, University Hospital of Munster, University of Munster
Career Start Year 1990
Number of shared co-authors 2
Joan Albanell
Hospital del Mar Research Institute
Career Start Year 1990
Number of shared co-authors 11
Lynn G Dressler
Duke University Research Institute
Career Start Year 1985
Number of shared co-authors 7
Gottfried E Konecny
David Geffen School of Medicine at University of California Los Angeles
Career Start Year 1984
Number of shared co-authors 14
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 10
Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
Career Start Year 1983
Number of shared co-authors 28
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 2
Christopher C Benz
Buck Institute for Research on Aging
Career Start Year 1977
Number of shared co-authors 9
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 11
Anna DeFazio
Westmead Hospital
Career Start Year 1972
Number of shared co-authors 21

Collaborators

Daniel Rea
Institute of Cancer and Genomic Sciences, The University of Birmingham
Co-authored papers 34
Cornelis J H van de Velde
Leiden University Medical Center: Leids Universitair Medisch Centrum.
Co-authored papers 26
Alison F Munro
Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital
Co-authored papers 23
Tammy Piper
University of Edinburgh
Co-authored papers 21
Janet A Dunn
Warwick Clinical Trials Unit, University of Warwick
Co-authored papers 20
Caroline Seynaeve
Erasmus Medical Center
Co-authored papers 19
Melanie Spears
Ontario Institute for Cancer Research
Co-authored papers 18
Elizabeth Mallon
Queen Elizabeth University Hospital
Co-authored papers 18
Christos Markopoulos
National and Kapodistrian University of Athens
Co-authored papers 16
Chris Twelves
Leeds Teaching Hospitals NHS Trust, University of Leeds
Co-authored papers 16
Robert E Denroche
Ontario Institute for Cancer Research
Co-authored papers 15
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers 15
Jane Bayani
Ontario Institute for Cancer Research
Co-authored papers 15
Annette Hasenburg
University Medical Center, Johannes Gutenberg University Mainz
Co-authored papers 15
Vicky S Sabine
University of Guelph
Co-authored papers 14
Julie M Wilson
Ontario Institute for Cancer Research
Co-authored papers 14
Gun Ho Jang
Ontario Institute for Cancer Research
Co-authored papers 14
Luc Dirix
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Co-authored papers 13
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 11
Paul C Boutros
University of California los angeles
Co-authored papers 11
Robert C Stein
12 University College London Hospitals National Health Service Foundation Trust
Co-authored papers 11
Dianne Chadwick
University Health Network
Co-authored papers 10
Christos Sotiriou
Co-authored papers 10
Faiyaz Notta
2Ontario Institute for Cancer Research
Co-authored papers 10
Cindy Q Yao
Ontario Institute for Cancer Research
Co-authored papers 9
Cassandra L Brookes
Leicester Clinical Trials Unit, University of Leicester
Co-authored papers 9
Dirk G Kieback
Helios Medical Centre
Co-authored papers 9
David L Rimm
Yale University School of Medicine
Co-authored papers 9
Karen J Taylor
University of Edinburgh
Co-authored papers 8
Mary Anne Quintayo
Ontario Institute of Cancer Research, MaRS Institute
Co-authored papers 8
Release 1.2